Found: 23
Select item for more details and to access through your institution.
Designing safe drug names.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Real-World Treatment Patterns, Healthcare Resource Utilization, and Costs for Patients with Newly Diagnosed Systolic versus Diastolic Heart Failure.
- Published in:
- American Health & Drug Benefits, 2020, v. 13, n. 4, p. 166
- By:
- Publication type:
- Article
Cardiovascular-Related Healthcare Resource Utilization and Costs in Patients with Hypertension Switching from Metoprolol to Nebivolol.
- Published in:
- American Health & Drug Benefits, 2015, v. 8, n. 2, p. 71
- By:
- Publication type:
- Article
Comparison of claims vs patient-reported adherence measures and associated outcomes among patients with nonvalvular atrial fibrillation using oral anticoagulant therapy.
- Published in:
- Patient Preference & Adherence, 2018, v. 12, p. 105, doi. 10.2147/PPA.S148697
- By:
- Publication type:
- Article
Impact and factors associated with nighttime and early morning symptoms among patients with chronic obstructive pulmonary disease.
- Published in:
- International Journal of COPD, 2015, p. 577, doi. 10.2147/COPD.S76157
- By:
- Publication type:
- Article
Impact and factors associated with nighttime and early morning symptoms among patients with chronic obstructive pulmonary disease.
- Published in:
- International Journal of COPD, 2015, v. 10, p. 577, doi. 10.2147/COPD.S76157
- By:
- Publication type:
- Article
Exacerbations among chronic bronchitis patients treated with maintenance medications from a US managed care population: an administrative claims data analysis.
- Published in:
- International Journal of COPD, 2013, v. 8, p. 175, doi. 10.2147/COPD.S40437
- By:
- Publication type:
- Article
Medication use among patients with Crohn's disease or ulcerative colitis before and after the initiation of advanced therapy.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Characteristics affecting oral anticoagulant therapy choice among patients with non-valvular atrial fibrillation: a retrospective claims analysis.
- Published in:
- BMC Health Services Research, 2014, v. 14, n. 1, p. 310, doi. 10.1186/1472-6963-14-310
- By:
- Publication type:
- Article
Characteristics affecting oral anticoagulant therapy choice among patients with non-valvular atrial fibrillation: a retrospective claims analysis.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Prevalence and burden of illness of treated hemolytic neonatal hyperbilirubinemia in a privately insured population in the United States.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Incidence of osteonecrosis of the jaw among users of bisphosphonates with selected cancers or osteoporosis Incidence of osteonecrosis of the jaw among users of bisphosphonates with selected cancers or osteoporosis.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2012, v. 21, n. 8, p. 810, doi. 10.1002/pds.3292
- By:
- Publication type:
- Article
Frequency estimates from prescription drug datasets (revision of #04-11-066A).
- Published in:
- Pharmacoepidemiology & Drug Safety, 2006, v. 15, n. 7, p. 512, doi. 10.1002/pds.1149
- By:
- Publication type:
- Article
Proton Pump Inhibitor Utilization Patterns in Infants.
- Published in:
- Journal of Pediatric Gastroenterology & Nutrition, 2007, v. 45, n. 4, p. 421, doi. 10.1097/MPG.0b013e31812e0149
- By:
- Publication type:
- Article
Pain Medication and Corticosteroid Use in Ankylosing Spondylitis, Psoriatic Arthritis, and Rheumatoid Arthritis in the United States: A Retrospective Observational Study.
- Published in:
- Rheumatology & Therapy, 2021, v. 8, n. 3, p. 1371, doi. 10.1007/s40744-021-00344-6
- By:
- Publication type:
- Article
The Impact of Ocular Adverse Effects in Patients Treated With Topical Prostaglandin Analogs: Changes in Prescription Patterns and Patient Persistence.
- Published in:
- Journal of Ocular Pharmacology & Therapeutics, 2009, v. 25, n. 2, p. 145, doi. 10.1089/jop.2008.0072
- By:
- Publication type:
- Article
Impact of adherence to disease-modifying therapies on clinical and economic outcomes among patients with multiple sclerosis.
- Published in:
- Advances in Therapy, 2011, v. 28, n. 1, p. 51, doi. 10.1007/s12325-010-0093-7
- By:
- Publication type:
- Article
Holistic View of Autografting Patients by Percentage of Total Body Surface Area Burned: Medical Record Abstraction Integrated with Administrative Claims.
- Published in:
- ClinicoEconomics & Outcomes Research, 2023, v. 15, p. 251, doi. 10.2147/CEOR.S401003
- By:
- Publication type:
- Article
1271-PUB: Real-World Effectiveness of Newly Initiated Once-Weekly Semaglutide (sema OW) by Prescriber Specialty.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-1271-PUB
- By:
- Publication type:
- Article
86-LB: Real-World Effectiveness of Oral Semaglutide (OS) from a U.S. Commercially Insured and Medicare Advantage Population.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-86-LB
- By:
- Publication type:
- Article
683-P: Real-World Evaluation of Once-Weekly Semaglutide (Sema OW) in Patients Newly Initiating GLP-1 Agonist Therapy.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-683-P
- By:
- Publication type:
- Article
652-P: Real-World Effectiveness of Once-Weekly Semaglutide (sema OW) from a U.S. Commercially Insured and Medicare Advantage Population.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-652-P
- By:
- Publication type:
- Article
653-P: Evaluating Antidiabetic Medication Treatment Patterns in T2D Patients Initiating Once-Weekly Semaglutide (sema OW).
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-653-P
- By:
- Publication type:
- Article